Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, drug interactions, dosage and administration, and place in therapy of atomoxetine in the treatment of attention-deficit ...

Clinical trial data indicate that atomoxetine is safe and well tolerated for the treatment of ADHD; however, safety data about long-term use (greater than one year) are unavailable. Adverse events ...

Citation: Managing adult ADHD: Comprehensive study compares stimulants, atomoxetine and non-pharmacological therapies (2024, December 18) retrieved 6 January 2025 from https://medicalxpress.com ...

Stimulants and atomoxetine are the only effective interventions to reduce short-term adult ADHD symptoms, yet show limited evidence for long-term outcomes and quality of life improvements ...